Mohammad Houshmand, Ph.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Mohammad Houshmand's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Mohammad Houshmand has written about over time.
BiomimeticsBone Marrow CellsDrug Evaluation, PreclinicalMesenchymal Stem CellsCell CycleTumor Cells, CulturedHematologic NeoplasmsCytarabineLeukemia, Erythroblastic, AcuteLeukemia, Myeloid, AcuteNeoplastic Stem CellsDrug Resistance, NeoplasmLeukemia, Myelogenous, Chronic, BCR-ABL PositiveProtein Kinase InhibitorsBiphenyl CompoundsOxidoreductases Acting on CH-CH Group DonorsFusion Proteins, bcr-abl
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Biomimetics | 1 | 2017 | 2017 | January 2017 |
| Bone Marrow Cells | 1 | 2017 | 2017 | January 2017 |
| Drug Evaluation, Preclinical | 1 | 2017 | 2017 | January 2017 |
| Mesenchymal Stem Cells | 1 | 2017 | 2017 | January 2017 |
| Cell Cycle | 2 | 2017 | 2018 | August 2017 |
| Tumor Cells, Cultured | 2 | 2017 | 2018 | August 2017 |
| Hematologic Neoplasms | 1 | 2018 | 2018 | March 2018 |
| Cytarabine | 1 | 2018 | 2018 | November 2018 |
| Leukemia, Erythroblastic, Acute | 1 | 2018 | 2018 | November 2018 |
| Leukemia, Myeloid, Acute | 2 | 2017 | 2021 | February 2019 |
| Neoplastic Stem Cells | 1 | 2019 | 2019 | May 2019 |
| Drug Resistance, Neoplasm | 2 | 2017 | 2022 | October 2019 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2019 | 2022 | December 2020 |
| Protein Kinase Inhibitors | 2 | 2019 | 2022 | December 2020 |
| Biphenyl Compounds | 1 | 2021 | 2021 | April 2021 |
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2021 | 2021 | April 2021 |
| Fusion Proteins, bcr-abl | 1 | 2022 | 2022 | June 2022 |